Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis
Study sponsor: Pliant Therapeutics, Inc. · PLRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-02-01Actual
Enrollment · participants120Actual
Source updated2024-06-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.